Neurocrine Biosciences (NBIX) Gross Margin Growth (1y) (2018 - 2026)
Neurocrine Biosciences (NBIX) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | -712.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -92.00 |
| Mar 31, 2026 | -9.00 |
| Dec 31, 2025 | -70.00 |
| Sep 30, 2025 | -48.00 |
| Jun 30, 2025 | -8.00 |
| Mar 31, 2025 | -15.00 |
| Dec 31, 2024 | 17.00 |
| Sep 30, 2024 | 96.00 |
| Jun 30, 2024 | 98.00 |
| Mar 31, 2024 | 57.00 |
| Dec 31, 2023 | 22.00 |
| Sep 30, 2023 | -67.00 |
| Jun 30, 2023 | 2,146.00 |
| Mar 31, 2023 | -54.00 |
| Dec 31, 2022 | -55.00 |
| Sep 30, 2022 | -15.00 |
| Jun 30, 2022 | -2,293.00 |
| Mar 31, 2022 | -26.00 |
| Dec 31, 2021 | -14.00 |
| Sep 30, 2021 | -37.00 |